HRAS and squamous cell carcinoma: Although the higher relative level of HRAS gene expression was observed in the group of patients with squamous cell carcinoma subtypes of NSCLC (N = 23) than in the group with adenocarcinoma (N = 16), this difference was not statistically significant (p = 0.065; Fig. 1b).